For citations:
Granatkin M.A., Nikitin E.A., Kislova M.I., Mikhailov E.S., Doronin V.A., Minenko S.V., Okuneva M.M., Antonova A.V., Degtyareva N.V., Pochtar M.E., Lugovskaya S.A., Kobzev Yu.N., Ptushkin V.V., Rimashevskaya E.V. Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience. Oncohematology. 2023;18(1):12-19. (In Russ.) https://doi.org/10.17650/1818-8346-2023-18-1-12-19
Email this article 